Patents by Inventor James Davidson

James Davidson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20170112512
    Abstract: A medical device, configured to perform an endovascular therapy, e.g., thrombectomy, can comprise an elongate manipulation member having a first connection member proximate a distal end of the elongate manipulation member, and an intervention member having a second connection member proximate a proximal end of the intervention member. The second connection member can be connected to the first connection member such that the first connection member can rotate relative to the second connection member.
    Type: Application
    Filed: October 23, 2015
    Publication date: April 27, 2017
    Inventors: James DAVIDSON, Andy HUYNH, Kevin NGUYEN
  • Publication number: 20170089463
    Abstract: A metal static gasket and method of construction thereof is provided. The gasket includes at least one metal layer. The at least one metal layer has opposite sides with at least one through opening extending through the opposite sides configured to register with an opening to be sealed and at least one raised annular seal bead extending at least in part about the at least one through opening. At least one protrusion extends outwardly from at least one of the sides, wherein the at least one protrusion prevents complete flattening of the at least one seal bead. The at least one protrusion has a plurality of discrete layers of metal deposited on one another via an additive manufacture process, wherein the protrusion is formed having a hollow region extending therein.
    Type: Application
    Filed: September 23, 2016
    Publication date: March 30, 2017
    Inventors: Thomas William Swasey, Edward Storrs Widder, Michael James Davidson, Brent Sedlar, Jeri Lynn Cochran
  • Patent number: 9592139
    Abstract: Stents can become twisted during deployment within tortuous vessels such that proper expansion against the vessel wall is inhibited. Stents can be twisted prior to deployment in a direction opposite the direction of twisting during deployment to facilitate full expansion of the stent against the vessel wall along the stent's entire length.
    Type: Grant
    Filed: December 20, 2013
    Date of Patent: March 14, 2017
    Assignee: COVIDIEN LP
    Inventors: James A. Davidson, Masoud Molaei
  • Publication number: 20160279406
    Abstract: Treatment of an aneurysm or other vascular defect can be facilitated or enhanced by a galvanic cell formed by an implantable medical device configured to be implanted at or within the aneurysm or other vascular defect. The implantable medical device can include a primary structure including an anodic metal and a cathodic metal. The anodic metal and the cathodic metal each form a fraction of a total surface area of the primary structure. A galvanic cell formed by the anodic metal and the cathodic metal is configured to induce a galvanic voltage within blood for a duration of time to promote thrombosis. The thickness of the anodic metal can be less than or equal to 5 ?m, for example, to provide galvanic activity for between 5 and 30 minutes.
    Type: Application
    Filed: March 27, 2015
    Publication date: September 29, 2016
    Inventor: James Davidson
  • Publication number: 20160235528
    Abstract: A treatment for bioprosthetic tissue used in implants or for assembled bioprosthetic heart valves to reduce in vivo calcification. The method includes applying a calcification mitigant such as a capping agent or an antioxidant to the tissue to specifically inhibit oxidation in tissue. Also, the method can be used to inhibit oxidation in dehydrated tissue. The capping agent suppresses the formation of binding sites in the tissue that are exposed or generated by the oxidation and otherwise would, upon implant, attract calcium, phosphate, immunogenic factors, or other precursors to calcification. In one method, tissue leaflets in assembled bioprosthetic heart valves are pretreated with an aldehyde capping agent prior to dehydration and sterilization.
    Type: Application
    Filed: April 25, 2016
    Publication date: August 18, 2016
    Inventors: Jeffrey S. Dove, Darin P. Dobler, James A. Davidson, Gregory A. Wright
  • Patent number: 9320830
    Abstract: A treatment for bioprosthetic tissue used in implants or for assembled bioprosthetic heart valves to reduce in vivo calcification. The method includes applying a calcification mitigant such as a capping agent or an antioxidant to the tissue to specifically inhibit oxidation in tissue. Also, the method can be used to inhibit oxidation in dehydrated tissue. The capping agent suppresses the formation of binding sites in the tissue that are exposed or generated by the oxidation and otherwise would, upon implant, attract calcium, phosphate, immunogenic factors, or other precursors to calcification. In one method, tissue leaflets in assembled bioprosthetic heart valves are pretreated with an aldehyde capping agent prior to dehydration and sterilization.
    Type: Grant
    Filed: May 8, 2015
    Date of Patent: April 26, 2016
    Assignee: Edwards Lifesciences Corporation
    Inventors: Jeffrey S. Dove, Darin P. Dobler, James A. Davidson, Gregory A. Wright
  • Publication number: 20160071231
    Abstract: Methods of integrity checking digitally displayed data in a display system having a display comprising a pixel array and a display system having a CPU configured to output data, a display screen comprising a pixel array with viewable and non-viewable areas, a GPU configured to receive the outputted data from the CPU and graphically render the information on the viewable area of the display screen, and a GIM engine configured to determine the integrity of drawn graphical information.
    Type: Application
    Filed: September 4, 2015
    Publication date: March 10, 2016
    Inventors: Roger Anthony BARGH, Timothy John ROBERTS, Michael Paul JENKINS, William James DAVIDSON, Michael John ALLEN, Damian Francis MINIHAN, Timothy George RILEY, Steven Anthony MARTIN, Gary QUELCUTI, Mark Andrew Paul EDWARDS
  • Publication number: 20150314042
    Abstract: A bioprosthetic tissue having a reduced propensity to calcify in vivo, the bioprosthetic tissue. The bioprosthetic tissue comprises an aldehyde cross-linked and stressed bioprosthetic tissue comprising exposed calcium, phosphate or immunogenic binding sites that have been reacted with a calcification mitigant. The bioprosthetic tissue has a reduced propensity to calcify in vivo as compared to aldehyde cross-linked bioprosthetic tissue that has not been stressed and reacted with the calcification mitigant.
    Type: Application
    Filed: July 13, 2015
    Publication date: November 5, 2015
    Inventors: James A. Davidson, Jeffrey S. Dove, Darin P. Dobler
  • Publication number: 20150267844
    Abstract: Cable lacing tie devices and methods of using the same are disclosed. The cable lacing tie devices include a head assembly and a cable lacing tape. The head assembly being configured to retain a first portion of the cable lacing tape within the head assembly and having a length of the cable lacing tape extending from the head assembly. The head assembly further adapted to retain a second portion of the cable lacing tape extending from the head assembly. The methods of using the cable lacing tie devices include retaining a first portion of a cable lacing tape in a head assembly, looping the cable lacing tape around a plurality of objects, and retaining a second portion of the cable lacing tape within the head assembly.
    Type: Application
    Filed: March 24, 2014
    Publication date: September 24, 2015
    Applicant: IDEAL INDUSTRIES, INC.
    Inventors: Alan E. Zantout, Robert W. Sutter, Michael Weiby, James Davidson
  • Publication number: 20150266636
    Abstract: A cable lacing tie device includes a head assembly and a cable lacing tape. The head assembly being configured to retain a first portion of the cable lacing tape within the head assembly and having a length of the cable lacing tape extending from the head assembly. The head assembly further adapted to retain a second portion of the cable lacing tape extending from the head assembly. The methods of using the cable lacing tie devices include retaining a first portion of a cable lacing tape in a head assembly, looping the cable lacing tape around a plurality of objects, and retaining a second portion of the cable lacing tape within the head assembly.
    Type: Application
    Filed: October 29, 2014
    Publication date: September 24, 2015
    Inventors: Alan E. Zantout, Robert W. Sutter, Michael Weiby, James Davidson
  • Publication number: 20150238659
    Abstract: A treatment for bioprosthetic tissue used in implants or for assembled bioprosthetic heart valves to reduce in vivo calcification. The method includes applying a calcification mitigant such as a capping agent or an antioxidant to the tissue to specifically inhibit oxidation in tissue. Also, the method can be used to inhibit oxidation in dehydrated tissue. The capping agent suppresses the formation of binding sites in the tissue that are exposed or generated by the oxidation and otherwise would, upon implant, attract calcium, phosphate, immunogenic factors, or other precursors to calcification. In one method, tissue leaflets in assembled bioprosthetic heart valves are pretreated with an aldehyde capping agent prior to dehydration and sterilization.
    Type: Application
    Filed: May 8, 2015
    Publication date: August 27, 2015
    Inventors: Jeffrey S. Dove, Darin P. Dobler, James A. Davidson, Gregory A. Wright
  • Publication number: 20150230922
    Abstract: Disclosed prosthetic valves can comprise a sewing ring configured to secure the valve to an implantation site. Some disclosed valves comprise a resiliently collapsible frame having a neutral configuration and a collapsed deployment configuration. Some disclosed frames can self-expand to the neutral configuration when released from the collapsed deployment configuration. Collapsing a disclosed valve can provide convenient access to the sewing ring, such as for securing the valve to the implantation site, as well as for the insertion of the valve through relatively small surgical incisions. Examples of delivery systems and methods for deploying the valves exhibit reduced patient trauma.
    Type: Application
    Filed: March 19, 2015
    Publication date: August 20, 2015
    Inventors: Hengchu Cao, Brian S. Conklin, Paul A. Schmidt, Grace M. Kim, James A. Davidson, Hoa T. Tran, Kristy L. Tam
  • Publication number: 20150173759
    Abstract: A device and method for deploying self-cinching surgical clips. The device accesses at least two layers of tissue or material from only one side of the tissue or material and punctures through the two layers of tissue or material. The various configurations of clips disclosed herein are made of a superelastic material such as Nitinol, and have a constrained and a relaxed state, and no sharp edges or tips so as to reduce tissue irritation following deployment. The clip is disposed within the housing of the delivery device and held in a constrained state by a tube assembly until deployment wherein the clip assumes its relaxed state, where the ends of the clip are brought into close approximation, thereby securing the layers of tissue or material together.
    Type: Application
    Filed: March 3, 2015
    Publication date: June 25, 2015
    Inventors: Brian S. Conklin, James A. Davidson, Ralph Schneider
  • Publication number: 20150133990
    Abstract: A medical device configured to perform an endovascular therapy can include an elongate manipulation member and an intervention member. The elongate manipulation member can include a distal end portion. The intervention member can include a proximal end portion and a mesh. The proximal end portion can be coupled with the distal end portion of the elongate manipulation member. The mesh can have a plurality of cells in a tubular configuration and being compressible to a collapsed configuration for delivery to an endovascular treatment site through a catheter and being self-expandable from the collapsed configuration to an expanded configuration. The mesh can include an anodic metal and a cathodic metal. The anodic metal and the cathodic metal can each form a fraction of a total surface area of the mesh.
    Type: Application
    Filed: November 13, 2014
    Publication date: May 14, 2015
    Inventor: James DAVIDSON
  • Patent number: 9029418
    Abstract: A treatment for bioprosthetic tissue used in implants or for assembled bioprosthetic heart valves to reduce in vivo calcification. The method includes applying a calcification mitigant such as a capping agent or an antioxidant to the tissue to specifically inhibit oxidation in tissue. Also, the method can be used to inhibit oxidation in dehydrated tissue. The capping agent suppresses the formation of binding sites in the tissue that are exposed or generated by the oxidation and otherwise would, upon implant, attract calcium, phosphate, immunogenic factors, or other precursors to calcification. In one method, tissue leaflets in assembled bioprosthetic heart valves are pretreated with an aldehyde capping agent prior to dehydration and sterilization.
    Type: Grant
    Filed: December 23, 2013
    Date of Patent: May 12, 2015
    Assignee: Edwards Lifesciences Corporation
    Inventors: Jeffrey S. Dove, Darin P. Dobler, James A. Davidson, Gregory A. Wright
  • Publication number: 20150100113
    Abstract: Stents can become twisted during deployment within tortuous vessels such that proper expansion against the vessel wall is inhibited. Stents can be twisted prior to deployment in a direction opposite the direction of twisting during deployment to facilitate full expansion of the stent against the vessel wall along the stent's entire length.
    Type: Application
    Filed: December 20, 2013
    Publication date: April 9, 2015
    Applicant: COVIDIEN LP
    Inventors: James A. DAVIDSON, Masoud MOLAEI
  • Patent number: 8986374
    Abstract: Disclosed prosthetic valves can comprise a sewing ring configured to secure the valve to an implantation site. Some disclosed valves comprise a resiliently collapsible frame having a neutral configuration and a collapsed deployment configuration. Some disclosed frames can self-expand to the neutral configuration when released from the collapsed deployment configuration. Collapsing a disclosed valve can provide convenient access to the sewing ring, such as for securing the valve to the implantation site, as well as for the insertion of the valve through relatively small surgical incisions.
    Type: Grant
    Filed: May 10, 2011
    Date of Patent: March 24, 2015
    Assignee: Edwards Lifesciences Corporation
    Inventors: Hengchu Cao, Brian Conklin, Paul Schmidt, Grace Myong Kim, James A. Davidson, Hoa Trinh Tran, Kristy Luong Tam
  • Publication number: 20150080937
    Abstract: A medical device, configured to perform an endovascular therapy, e.g., thrombectomy, can comprise an elongate manipulation member and an intervention member. The intervention member can comprise a proximal end portion and a mesh. The proximal end portion can be coupled with the distal end portion of the elongate manipulation member. The mesh can have a plurality of cells and, be compressible to a collapsed configuration for delivery to an endovascular treatment site through a catheter, and be self-expandable from the collapsed configuration to an expanded configuration. At least a portion of the mesh, from a first location to a second location along the mesh, can be configured such that an amount of cell deformation in response to longitudinally directed tensile forces decreases by less than 5% or increases in a distal direction along the portion of the mesh.
    Type: Application
    Filed: September 13, 2013
    Publication date: March 19, 2015
    Applicant: COVIDIEN LP
    Inventor: James A. DAVIDSON
  • Patent number: 8971510
    Abstract: The present invention resides in one aspect in a system including a user operable portable radio communication device and a server. The invention includes the portable radio communication device comprising a sensor adapted to allow automatic input of data to the portable radio communication device, a controller for controlling the device, a browser adapted to download content from the server, the controller being arranged to be responsive to data input via said sensor so as control the browser to download content from a server associated with the input data, means for providing for information personal to a user, and contextualization means configured to contextualize the downloaded content with the personal information.
    Type: Grant
    Filed: May 21, 2010
    Date of Patent: March 3, 2015
    Assignee: Nokia Corporation
    Inventors: Brian James Davidson, Steven Andrew Mote, Robert Clifford Newstead, Ronald J. Lander, David Fisher
  • Patent number: D770857
    Type: Grant
    Filed: October 13, 2015
    Date of Patent: November 8, 2016
    Assignee: Syrup Systems of Lafayette, Inc.
    Inventor: James Davidson, IV